Rallis India reported a challenging second quarter for fiscal year 2027, with Profit After Tax declining 17 percent year-on-year to Rs 85 crore and EBITDA falling 18 percent to Rs 126 crore. While total revenue remained flat at Rs 858 crore, the company experienced a sharp segment-wise divergence.
Key Financial Metrics
- Rs 858 crore: Total revenue for Q2FY27, remaining flat.
- Rs 85 crore: Profit After Tax for the quarter, reflecting a 17 percent year-on-year decline.
- Rs 126 crore: EBITDA for Q2FY27, falling 18 percent.
- 4 percent: Revenue growth recorded by the Crop Care business segment.
- 31 percent: Revenue decline experienced by the Seeds business segment.
The firm faced external pressures during the quarter, specifically citing delayed sowing and disruptions caused by weather conditions. Market skeptics had previously misjudged the stock trajectory by focusing strictly on short-term headwinds and sector-specific challenges.
Segment Performance Highlights
- Crop Care: Top-line revenue grew by 4 percent, fueled by a 17 percent increase in the B2B segment and a recovery in the Contract Manufacturing portfolio.
- Domestic Formulations: B2C performance remained consistent with the previous year, featuring 16 percent growth in herbicides and flat growth in insecticides.
- Soil And Plant Health: This division experienced a 22 percent increase, attributed primarily to growth in pricing.
- Seeds Business: Segment revenue declined 31 percent due to increased product returns from the Kharif season.
- Product Additions: Rallis introduced four new Crop Care products in Q2FY27, consisting of Silentra as an insecticide, Marcellus and Blitox Super as fungicides, and Trynage as a herbicide.
Despite bearish expectations regarding short-term operational hurdles, the company demonstrated operational resilience and strategic adaptability. Investors navigating the volatile agricultural input market continued to monitor the long-term fundamentals and recovery potential across its core divisions.